Hunt Jonathan Robert Insider Trades

Insider Trading History

Track insider trading activity for Hunt Jonathan Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Accounting Officer
Holding Value $293k 90,000 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$482k 90,000 shares
$5.35
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Accounting Officer
Holding Value $194k 59,800 shares
Last Trade
Nov 13, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.3k 11,000 shares
$2.03
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Accounting Officer
Holding Value $244k 75,000 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 75,000 shares
$2.46
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $159k 48,800 shares
Last Trade
Nov 25, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49k 12,829 shares
$3.82
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $325k 100,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.07M 100,000 shares
$10.65
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $117k 35,971 shares
Last Trade
Jun 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.7k 1,800 shares
$9.82
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $1.11M 341,716 shares
Last Trade
May 31, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$35k 25,006 shares
$1.40
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $1.03M 316,710 shares
Last Trade
Dec 18, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$32.5k 125,000 shares
$0.26
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
Chief Financial Officer
Holding Value $122k 316,710 shares
Last Trade
Dec 18, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48k 125,000 shares
$0.38
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Chief Financial Officer
Holding Value $971k 2,527,429 shares
Last Trade
Dec 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$480k 1,248,776 shares
$0.38
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $8.21M 2,527,429 shares
Last Trade
Dec 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 1,248,776 shares
$0.24
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $623k 191,710 shares
Last Trade
Dec 05, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.9k 32,200 shares
$0.34
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
Chief Financial Officer
Holding Value $73.6k 191,710 shares
Last Trade
Dec 05, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.9k 32,200 shares
$0.34
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $518k 159,510 shares
Last Trade
Dec 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.2k 53,204 shares
$0.38
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
Chief Financial Officer
Holding Value $61.3k 159,510 shares
Last Trade
Dec 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.2k 53,204 shares
$0.38
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $4.16M 1,278,653 shares
Last Trade
Jul 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$157k 475,000 shares
$0.33
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
Chief Financial Officer
Holding Value $491k 1,278,653 shares
Last Trade
Jul 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$313k 950,000 shares
$0.33
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $345k 106,306 shares
Last Trade
Jun 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.45k 25,675 shares
$0.29
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
Chief Financial Officer
Holding Value $40.8k 106,306 shares
Last Trade
Jun 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.3k 39,000 shares
$0.29
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
Chief Financial Officer
Holding Value $262k 80,631 shares
Last Trade
Jun 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.73k 13,325 shares
$0.28
$3.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up